199 related articles for article (PubMed ID: 22201186)
21. Ceramide promotes apoptosis in lung cancer-derived A549 cells by a mechanism involving c-Jun NH2-terminal kinase.
Kurinna SM; Tsao CC; Nica AF; Jiffar T; Ruvolo PP
Cancer Res; 2004 Nov; 64(21):7852-6. PubMed ID: 15520191
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of JNK potentiates temozolomide-induced cytotoxicity in U87MG glioblastoma cells via suppression of Akt phosphorylation.
Vo VA; Lee JW; Lee HJ; Chun W; Lim SY; Kim SS
Anticancer Res; 2014 Oct; 34(10):5509-15. PubMed ID: 25275048
[TBL] [Abstract][Full Text] [Related]
23. Glycogen synthase kinase-3 inhibition sensitizes human induced pluripotent stem cells to thiol-containing antioxidants induced apoptosis.
Tu C; Xu R; Koleti M; Zoldan J
Stem Cell Res; 2017 Aug; 23():182-187. PubMed ID: 28772167
[TBL] [Abstract][Full Text] [Related]
24. Anti-proliferative and pro-apoptotic effects of 3,3'-diindolylmethane in human cervical cancer cells.
Zhu J; Li Y; Guan C; Chen Z
Oncol Rep; 2012 Sep; 28(3):1063-8. PubMed ID: 22736073
[TBL] [Abstract][Full Text] [Related]
25. Celecoxib promotes c-FLIP degradation through Akt-independent inhibition of GSK3.
Chen S; Cao W; Yue P; Hao C; Khuri FR; Sun SY
Cancer Res; 2011 Oct; 71(19):6270-81. PubMed ID: 21868755
[TBL] [Abstract][Full Text] [Related]
26. Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression.
Liu H; Liang SL; Kumar S; Weyman CM; Liu W; Zhou A
Cancer Chemother Pharmacol; 2009 May; 63(6):997-1005. PubMed ID: 18766339
[TBL] [Abstract][Full Text] [Related]
27. Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets.
Aikin R; Maysinger D; Rosenberg L
Endocrinology; 2004 Oct; 145(10):4522-31. PubMed ID: 15242986
[TBL] [Abstract][Full Text] [Related]
28. Requirement for JNK-dependent upregulation of BimL in anti-IgM-induced apoptosis in murine B lymphoma cell lines WEHI-231 and CH31.
Takada E; Hata K; Mizuguchi J
Exp Cell Res; 2006 Nov; 312(19):3728-38. PubMed ID: 17007835
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells.
Tan J; Zhuang L; Leong HS; Iyer NG; Liu ET; Yu Q
Cancer Res; 2005 Oct; 65(19):9012-20. PubMed ID: 16204075
[TBL] [Abstract][Full Text] [Related]
30. Identification of an antiapoptotic protein complex at death receptors.
Sun M; Song L; Li Y; Zhou T; Jope RS
Cell Death Differ; 2008 Dec; 15(12):1887-900. PubMed ID: 18846110
[TBL] [Abstract][Full Text] [Related]
31. Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells.
Natalicchio A; De Stefano F; Orlando MR; Melchiorre M; Leonardini A; Cignarelli A; Labarbuta R; Marchetti P; Perrini S; Laviola L; Giorgino F
Endocrinology; 2010 May; 151(5):2019-29. PubMed ID: 20219981
[TBL] [Abstract][Full Text] [Related]
32. The marine natural product microsclerodermin A is a novel inhibitor of the nuclear factor kappa B and induces apoptosis in pancreatic cancer cells.
Guzmán EA; Maers K; Roberts J; Kemami-Wangun HV; Harmody D; Wright AE
Invest New Drugs; 2015 Feb; 33(1):86-94. PubMed ID: 25416019
[TBL] [Abstract][Full Text] [Related]
33. Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation.
Kotliarova S; Pastorino S; Kovell LC; Kotliarov Y; Song H; Zhang W; Bailey R; Maric D; Zenklusen JC; Lee J; Fine HA
Cancer Res; 2008 Aug; 68(16):6643-51. PubMed ID: 18701488
[TBL] [Abstract][Full Text] [Related]
34. Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis.
Morel C; Carlson SM; White FM; Davis RJ
Mol Cell Biol; 2009 Jul; 29(14):3845-52. PubMed ID: 19433446
[TBL] [Abstract][Full Text] [Related]
35. The conserved role of the AKT/GSK3 axis in cell survival and glycogen metabolism in Rhipicephalus (Boophilus) microplus embryo tick cell line BME26.
de Abreu LA; Calixto C; Waltero CF; Della Noce BP; Githaka NW; Seixas A; Parizi LF; Konnai S; Vaz Ida S; Ohashi K; Logullo C
Biochim Biophys Acta; 2013 Mar; 1830(3):2574-82. PubMed ID: 23274741
[TBL] [Abstract][Full Text] [Related]
36. Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression.
Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
HPB (Oxford); 2015 Sep; 17(9):770-6. PubMed ID: 26147011
[TBL] [Abstract][Full Text] [Related]
37. The JNK- and AKT/GSK3β- signaling pathways converge to regulate Puma induction and neuronal apoptosis induced by trophic factor deprivation.
Ambacher KK; Pitzul KB; Karajgikar M; Hamilton A; Ferguson SS; Cregan SP
PLoS One; 2012; 7(10):e46885. PubMed ID: 23056511
[TBL] [Abstract][Full Text] [Related]
38. Glycogen synthase kinase-3β is involved in ligand-dependent activation of transcription and cellular localization of the glucocorticoid receptor.
Rubio-Patiño C; Palmeri CM; Pérez-Perarnau A; Cosialls AM; Moncunill-Massaguer C; González-Gironès DM; Pons-Hernández L; López JM; Ventura F; Gil J; Pons G; Iglesias-Serret D
Mol Endocrinol; 2012 Sep; 26(9):1508-20. PubMed ID: 22771494
[TBL] [Abstract][Full Text] [Related]
39. CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells.
Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Choi J
PLoS One; 2013; 8(4):e60383. PubMed ID: 23565238
[TBL] [Abstract][Full Text] [Related]
40. The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma.
Li Z; Mbah NE; Overmeyer JH; Sarver JG; George S; Trabbic CJ; Erhardt PW; Maltese WA
BMC Cancer; 2019 Jan; 19(1):77. PubMed ID: 30651087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
